Aberrant interactions between Htt and MeCP2 is suggested to contribute to aberrant transcription in Huntington’s disease by regulating brain-derived neurotrophic factor (BDNF) levels [117]. The gene discussed is BDNF; the disease is juvenile Huntington disease.